Medical devices and methods for modulation of physiology using device-based surface chemistry

• US 20060177476A1
• Filed: 02/08/2005
• Published: 08/10/2006
• Est. Priority Date: 02/08/2005
• Status: Active Grant

• Current Assignee: Bruce N. Saffran
• Original Assignee: Bruce N. Saffran
• Inventors: Saffran, Bruce N.
• Granted Patent: US 9,050,393 B2
• Time in Patent Office: Days
• US Class Current: 424/423
• CPC Class Codes: A61L 31/005 Ingredients of undetermined constitution or reaction products thereof

Abstract

This invention provides implantable medical devices having at least one moiety attached to the surface capable of catalyzing a reaction in vivo. The implantable medical device has a body such as a stent with a surface adapted to be placed adjacent to a biological tissue or fluid. The body has at least one moiety attached to the surface which is capable of catalyzing a first reaction upon contacting a first substrate in the biological tissue or fluid. The moiety remains attached to the surface after the first reaction and is capable of catalyzing at least a second reaction upon contacting a second substrate. In preferred embodiments the moiety is capable of catalyzing a multitude of reactions as substrates come into contact and then leave the surface of the device.

Claims

1. An implantable medical device, comprising:

a body having a surface adapted to be placed adjacent to a biological tissue or fluid in vivo;

at least one moiety attached to the surface, wherein the moiety is capable of catalyzing a first reaction upon contacting a first substrate in the biological tissue or fluid; and

wherein the at least one moiety remains attached to the surface after the first reaction and is capable of catalyzing at least a second reaction upon contacting a second substrate.

2. A device according to claim 1, further comprising at least a second moiety attached to the surface.

3. A device according to claim 2, wherein each of the first and second moieties is capable of catalyzing a different reaction.

4. A device according to claim 1, wherein the moiety is a ligand capable of binding to a cell surface molecule.

5. A device according to claim 1, wherein the moiety is attached to the surface by a non-hydrolyzable bond.

6. A device according to claim 1, wherein the moiety is attached to the surface by a covalent bond.

7. A device according to claim 6, wherein the bond is a metaloxysilane.

8. A device according to claim 1, wherein the moiety comprises a protein.

9. A device according to claim 1, wherein the moiety comprises an aptamer.

10. A device according to claim 1, wherein the moiety comprises an enzyme.

11. A device according to claim 1, wherein the moiety comprises a growth factor.

12. A device according to claim 11, wherein the growth factor is epidermal growth factor.

13. A device according to claim 1, wherein the moiety comprises a hormone.

14. A device according to claim 1, wherein the moiety comprises a carbamide activated protein.

15. A device according to claim 1, wherein the moiety comprises a diopterine.

16. A device according to claim 15, wherein the diopterine is selected from the group consisting of FAD, FMN, and NADP.

17. A device according to claim 1, wherein the moiety comprises a redox compound.

18. A device according to claim 1, wherein the moiety comprises a nucleic acid.

19. A device according to claim 18, wherein the nucleic acid comprises a ribozyme.

20. A device according to claim 18, wherein the nucleic acid comprises an siRNA.

21. A device according to claim 1, wherein the moiety is capable of structural modification by application of energy to the device.

22. A device according to claim 1, wherein the moiety is photoisomerizable.

23. A device according to claim 22, wherein the moiety is convertible between cis to trans configuration upon exposure to a laser pulse.

24. A device according to claim 22, wherein the moiety is an azobenzine photoisomer.

25. A device according to claim 1, wherein the body is flexible.

26. A device according to claim 1, wherein the body comprises a flexible sheet.

27. A device according to claim 26, wherein the sheet has a plurality of pores.

28. A device according to claim 1, wherein the body comprises a polymeric material.

29. A device according to claim 28, wherein the polymeric material is selected from the group consisting of cellulose acetate, cellulose nitrate, silicone, polyethylene teraphthalate, polyurethane, polyamide, polyester, polyorthoester, polyanhydride, polyether sulfone, polycarbonate, polypropylene, high molecular weight polyethylene, and polytetrafluroethylene.

30. A device according to claim 1, wherein the body comprises a metallic material.

31. A device according to claim 30, wherein the metallic material is selected from the group consisting of platinum, gold, stainless steel, tantalum, titanium, nitinol, iconel, iridium, silver, and tungsten.

32. A device according to claim 1, wherein the implantable device is a stent.

33. A device according to claim 32, wherein the stent is a vascular stent.

34. A device according to claim 2, wherein the device comprises means for converting at least one of the first and second moieties between active and inactive states.

35. A device according to claim 34, further comprising a feed back loop for activating or deactivating at least one of the first and second moieties in response to a monitored feature.

36. A device according to claim 2, wherein at least one of the first and second moieties is capable of being activated or deactivated in response to an external stimulus.

37. A device according to claim 36, wherein the external stimulus is selected from the group consisting of light, a chemical compound, a magnetic field, and an electrical signal.

38. A device according to claim 1, wherein the substrate comprises a protein.

39. A device according to claim 1, wherein the substrate comprises a cell surface protein.

40. A device according to claim 1, wherein the substrate comprises a cell surface receptor.

41. A device according to claim 1, wherein the substrate comprises a drug.

42. A device according to claim 1, wherein the substrate comprises a prodrug.

43. A device according to claim 1, wherein the substrate comprises a growth factor receptor.

44. A device according to claim 43, wherein the growth factor receptor is epidermal growth factor receptor.

45. A device according to claim 1, wherein the substrate comprises a hormone.

46. A device according to claim 1, wherein the substrate comprises a nucleic acid.

47. A device according to claim 46, wherein the nucleic acid comprises a ribozyme.

48. A device according to claim 46, wherein the nucleic acid comprises an siRNA.

49. A device according to claim 1, wherein at least of the first reaction and the second reaction comprises a reaction regulated by activation of a cell membrane receptor.

50. A device according to claim 1, wherein at least of the first reaction and the second reaction comprises activation of a cytoplasmic kinase domain.

51. A device according to claim 1, wherein at least of the first reaction and the second reaction comprises conversion of a prodrug into a pharmaceutically active agent.

52. A method of making an implantable medical device, comprising:

providing a body having a surface adapted for placement adjacent to a biological tissue or fluid in vivo; and

attaching at least one chemical moiety to the surface, wherein the moiety is capable of catalyzing a first reaction upon contacting a first substrate in the biological tissue or fluid and remaining attached to the surface after the first reaction, and is capable of catalyzing at least a second reaction upon contact with a second substrate.

53. A method for catalyzing a physiological reaction in vivo, comprising:

providing an implantable device having a body and a surface thereon adapted to be placed adjacent to a biological tissue or fluid in vivo, and having at least one chemical moiety attached to the surface, wherein the moiety is capable of catalyzing a first reaction upon contacting a first substrate in the biological tissue or fluid and remaining attached to the surface after the first reaction, and is capable of catalyzing a second reaction upon contact with a second substrate; and

implanting the device into an animal or human such that the moiety contacts a biologically activatable substrate to catalyze a physiological reaction.